Utilizing an international, multi-institutional database, we developed a time-updated prediction model that integrated postoperative AFP trends with tumor burden, allowing for time-updated, dynamic risk assessments to improve recurrence prediction during outpatient follow-up. The gene discussed is AFP; the disease is neoplasm.